Medisave Women Cancer Screening Advanced is an advanced cancer screening package for women designed to assess important tumor markers associated with ovarian, breast, gastrointestinal, thyroid, and other cancers.
This package includes key cancer biomarkers such as CA-125, CA 15.3, CA 19.9, CEA, Calcitonin, Thyroglobulin, Alpha Fetoprotein (AFP), and Beta HCG, along with a complete hemogram to provide a broader assessment of overall health status.
Early screening plays an important role in preventive healthcare and helps doctors identify abnormal findings that may require further evaluation and monitoring.
🧪 TESTS INCLUDED IN THIS PACKAGE (36 TESTS)
🎗️ Cancer Markers (4 Tests)
- CA-125
- CA 15.3
- CA 19.9
- Carcinoembryonic Antigen (CEA)
🦋 Thyroid Cancer Markers (2 Tests)
- Calcitonin
- Thyroglobulin (TG)
🩸 Complete Hemogram (28 Tests)
- Hemoglobin
- Total Leucocyte Count (WBC)
- Total RBC
- Hematocrit (PCV)
- Platelet Count
- Plateletcrit (PCT)
- Mean Corpuscular Volume (MCV)
- Mean Corpuscular Hemoglobin (MCH)
- Mean Corpuscular Hemoglobin Concentration (MCHC)
- Red Cell Distribution Width (RDW-CV)
- Red Cell Distribution Width-SD (RDW-SD)
- Platelet Distribution Width (PDW)
- Platelet Large Cell Ratio (PLCR)
- Mean Platelet Volume (MPV)
- Neutrophils
- Lymphocytes
- Monocytes
- Eosinophils
- Basophils
- Neutrophils Absolute Count
- Lymphocytes Absolute Count
- Monocytes Absolute Count
- Eosinophils Absolute Count
- Basophils Absolute Count
- Immature Granulocytes (IG)
- Immature Granulocyte Percentage (IG%)
- Nucleated RBC
- Nucleated RBC %
👶 Pregnancy & Specialized Markers (2 Tests)
- Alpha Fetoprotein (AFP)
- Beta HCG
⭐ Key Benefits
- Advanced women's cancer screening
- Ovarian cancer marker assessment
- Breast cancer marker evaluation
- Gastrointestinal cancer marker screening
- Thyroid tumor marker analysis
- Preventive oncology health checkup
- Comprehensive blood health assessment
🏥 Recommended For
- Women above 30 years
- Family history of cancer
- Preventive annual health screening
- Women with unexplained weight loss
- Ovarian and breast health monitoring
- Oncology follow-up evaluations
- High-risk female populations
⚠️ Important Information
- Fasting may not be required for most tests
- Blood sample collection required
- Home sample collection may be available
- Results should be interpreted by a qualified physician
- Tumor markers are screening tools and not standalone diagnostic tests
